AstraZeneca PLC

AZN

GB0009895292

Pharmaceuticals

Market Closed - London S.E. Other stock markets 16:35:06 10/01/2025 GMT			5-day change	1st Jan Change
10,982.00 ^GBX	-0.05%		+3.66%	+4.91%

01-10	European Equities Traded in the US as American Depositary Receipts Lower in Friday Trading	MT
01-10	Annexon, Inc. Appoints William ?BJ? Jones to Its Board of Directors	CI

Trump-induced Pharma fears shouldn't be long-lived

November 19, 2024 at 04:16 pm

This Alphavalue article, the European leader in independent research, is only available to subscribers .

Alphavalue is exclusively on MarketScreener.
To unlock the article, SUBSCRIBE!

Already a customer? Log In

Latest news about AstraZeneca PLC

European Equities Traded in the US as American Depositary Receipts Lower in Friday Trading	01-10	MT
Annexon, Inc. Appoints William ?BJ? Jones to Its Board of Directors	01-10	CI
Innate Pharma to Focus on NK Cell Therapies, ADC Development to Accelerate Growth	01-10	MT
AstraZeneca breast cancer drug Lynparza given green light for NHS use	01-09	AN
Di adds Sampo to low-risk portfolio, SCA removed	01-09	FW
Johnson & Johnson Reports 'Statistically Significant' Data From Trial of Rybrevant, Lazcluze Combination to Treat Lung Cancer	01-07	MT
ASTRAZENECA : Buy rating from Berenberg	01-07	ZD
Berenberg Maintains AstraZeneca's Rating on Promising 2025 Pipeline	01-07	MT
ASTRAZENECA : Bernstein reiterates its Buy rating	01-07	ZD
ASTRAZENECA : JP Morgan maintains a Buy rating	01-06	ZD
Global markets live: Apple, Nvidia, Apple, Repsol, BYD...	01-02
A poor 2024 increases the odds of a brighter 2025	01-02
Hutchmed Says China's Medicines Regulator Accepts NDA With Priority Review for Orpathys, Tagrisso Combination	01-02	MT
Hutchmed China disposes of 45% stake in Shanghai joint venture	01-02	AN
China's Medical Regulator Accepts for Priority Review Hutchmed's Lung Cancer Treatment Application	01-02	MT
Stocks red ahead of US trade balance read	12-27	AN
Syncona investee sells assets to AstraZeneca for USD12 million	12-27	AN
Stockholm Bullets - Mendus sinks on terminated cooperation	12-27	FW
Stocks seen down as holiday sales stabilise	12-27	AN
Achilles Therapeutics Sells Technology Assets to AstraZeneca for $12 Million	12-24	DJ
Achilles Therapeutics Sells Technology Assets to AstraZeneca for $12 Million, Concluding Strategic Review; Shares Up	12-24	MT
London Shares Festive Ahead of Christmas Break; Vistry Slumps on Fresh Profit Warning	12-24	MT
Most European Bourses Track Higher Midday of Muted Tuesday Trading, Ahead of Holiday Break	12-24	MT
AstraZeneca, Daiichi Sankyo Withdraw EU Marketing Application for Lung Cancer Drug Candidate	12-24	MT
AstraZeneca Pulls EU Marketing Application for Lung Cancer Treatment Amid Regulatory Feedback	12-24	MT

AstraZeneca PLC is one of the world's leading pharmaceutical groups. Net sales break down by source of income as follows: - product sales (95.6%). Net sales break down by treatment area between oncology (39.2%), cardiovascular, renal and metabolic diseases (24.2%), respiratory and autoimmune diseases (13.9%), and other (22.7%; inflammatory diseases, neurological diseases, gastrointestinal and infectious diseases); - collaboration revenue (4.4%). Net sales are distributed geographically as follows: the United Kingdom (7.4%), Europe (21.2%), America (45.3%) and Africa-Asia-Australia (26.1%).

Employees

89,900

Sector

Pharmaceuticals

Calendar

12/01/2025 - JP Morgan Healthcare Conference

More about the company